2021 annual financial data

Seres Therapeutics 2021 Operating cash flow margin

Direct answer

Operating cash flow margin was 4.61%.

Operating income was -64.49M USD and net income was -65.58M USD.
Operating cash flow was 6.69M USD.

Get free Seres Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
144.93M USD
Operating income
-64.49M USD
Net income
-65.58M USD
Operating cash flow
6.69M USD